Why fertility preservation rates of transgender men are much lower than those of transgender women.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
05 2022
Historique:
received: 20 07 2021
revised: 07 11 2021
accepted: 07 01 2022
pubmed: 28 3 2022
medline: 11 5 2022
entrez: 27 3 2022
Statut: ppublish

Résumé

What are the fertility preservation rates of transgender women and transgender men, and what are the factors that affect their decision-making? This prospective study included 97 transgender women and 91 transgender men referred to the Gender Clinic of the study medical centre's Endocrinology Institute and to the Gan Meir Community Health Care Centre. The responders completed a 28-item questionnaire during 2018. Most of the transgender women and transgender men wished to parent a child (67.4% and 61.9%, respectively, P = 0.447), but only 40.4% of the transgender women and 5.8% of the transgender men used fertility preservation (P < 0.001). The main reasons for not pursuing fertility preservation were unwillingness to postpone gender-affirming treatment (58.8% and 74.0%, respectively, P = 0.076), preference to adopt a child (58.8% and 60.9%, respectively, P = 0.818) and cost (44.9% and 60.9%, respectively, P = 0.086). Factors related to the fertility preservation process itself were specifically chosen by transgender men compared with transgender women as the reason for not pursuing this treatment, including distress caused by the fertility preservation technique (60.3% versus 29.3%, respectively, P = 0.006), fear of gender dysphoria caused by hormonal treatment (63.5% versus 28.3%, P = 0.002) and concern over the attitude of medical staff (44% versus 19%, P = 0.027). Fertility preservation rates were considerably lower among transgender men than transgender women, strongly related to the fertility preservation process itself. Finding ways to overcome the obstacles confronted by transgender individuals, especially transgender men, will enhance their future biological parenting.

Identifiants

pubmed: 35339365
pii: S1472-6483(22)00029-3
doi: 10.1016/j.rbmo.2022.01.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

943-950

Informations de copyright

Copyright © 2022 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Sharon Alpern (S)

Sara Racine IVF Unit, Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Iris Yaish (I)

Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Gal Wagner-Kolasko (G)

Department of Family Medicine, Tel Aviv District, Clalit Gan Meir LGBT Clinic, Israel.

Yona Greenman (Y)

Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Yael Sofer (Y)

Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Dror Paltiel Lifshitz (D)

Department of Obstetrics and Gynecology, Sheba Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Hashomer, Israel.

Asnat Groutz (A)

Sara Racine IVF Unit, Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Foad Azem (F)

Sara Racine IVF Unit, Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Hadar Amir (H)

Sara Racine IVF Unit, Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel. Electronic address: hadarnmb@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH